Adavance Life Sciences to be Featured at Venturwires' Lifescience Portfolio Investment Conference
Company designated as one of most promising start-up biotechs

Woodridge, Ill, Oct. 17, 2002 -Advanced Life Sciences (ALS) will be featured as one of the 100 most promising start-up private biotech companies at VentureWire's 2002 Lifescience Portfolio Investment Conference on Tuesday, Oct. 22, in San Francisco. Michael T. Flavin, Ph.D., Advanced Life Sciences' CEO will present ALS at 9:15 a.m. before an audience of investors, analysts, biotech CEOs, journalists and representatives of large pharmaceutical companies.

Participating companies are looking for various stages of investment support. "This event represents a key networking opportunity for investment-seeking biotech companies, like Advanced Life Sciences, to showcase our technologies before an audience of investors, analysts, biotech CEOs, journalists and representatives of large pharmaceutical companies also from the Midwest", said Dr. Flavin.

Based in Woodridge, Ill., Advanced Life Sciences, Inc. (www.advancedlifesciences.com) is a privately held biopharmaceutical company that discovers and develops therapeutic compounds to fight infection, inflammation and cancer. The company bridges the gap between drug discovery and pharmaceutical commercialization, and focuses on diseases that have significant unmet medical needs in important markets.

###